Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Use of Ranks in One-Criterion Variance Analysis
1952 • 9,960 citations
The veterans administration cooperative urological research group's studies of cancer of the prostate
1973 • 607 citations
Estimating survival functions from the life table
1969 • 264 citations
Differences in Coronary Heart Disease in Framingham, Honolulu and Puerto Rico
1974 • 243 citations
Carcinoma of the Prostate: Treatment Comparisons
1967 • 209 citations
Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic Cancer
1973 • 167 citations
Controlled Clinical Trials in Urologic Oncology
1983 • 69 citations
Bladder Tumors and other Topics in Urological Oncology
1980 • 53 citations
Atherosclerosis and Cardiovascular Diseases
1987 • 48 citations
Role of Medroxyprogesterone in Endocrine-Related Tumors
1982 • 44 citations
Cancer of the Prostate and Kidney
1983 • 35 citations
A computer program for estimating survival functions from the life table
1970 • 23 citations
Review of the Veterans Administration Studies of Cancer of the Prostate and New Results Concerning Treatment of Stage I and II Tumours
1980 • 18 citations
EORTC protocols in prostatic cancer. An interim report.
1980 • 15 citations
On the analysis of response rates in studies of advanced disease.
1980 • 11 citations
Preliminary Results of Two Eortc Randomized Trials in Previously Untreated Patients with Advanced T3 — T4 Prostatic Cancer
1983 • 4 citations
Regulation of the contractile system of blood platelets
1980 • 2 citations